company background image
600351 logo

Yabao Pharmaceutical Group XSSC:600351 Stock Report

Last Price

CN¥6.09

Market Cap

CN¥4.4b

7D

-1.0%

1Y

-23.9%

Updated

22 Nov, 2024

Data

Company Financials

Yabao Pharmaceutical Group Co., Ltd

XSSC:600351 Stock Report

Market Cap: CN¥4.4b

600351 Stock Overview

Researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. More details

600351 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends5/6

Yabao Pharmaceutical Group Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Yabao Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥6.09
52 Week HighCN¥8.20
52 Week LowCN¥4.94
Beta0.26
11 Month Change0.33%
3 Month Change10.93%
1 Year Change-23.88%
33 Year Change-18.04%
5 Year Change9.73%
Change since IPO-37.35%

Recent News & Updates

Recent updates

Shareholder Returns

600351CN PharmaceuticalsCN Market
7D-1.0%1.0%-0.9%
1Y-23.9%-4.8%5.4%

Return vs Industry: 600351 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.

Return vs Market: 600351 underperformed the CN Market which returned 5.4% over the past year.

Price Volatility

Is 600351's price volatile compared to industry and market?
600351 volatility
600351 Average Weekly Movement5.4%
Pharmaceuticals Industry Average Movement7.2%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 600351 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 600351's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19784,142Wei Renwww.yabao.com.cn

Yabao Pharmaceutical Group Co., Ltd researches, develops, manufactures, and sells Chinese and Western medicines, and pharmaceutical packaging materials in China and internationally. The company provides pediatric products, cardiovascular and cerebrovascular products, endocrine products, women's health products, patches, and general health products. Yabao Pharmaceutical Group Co., Ltd was founded in 1978 and is based in Yuncheng, China.

Yabao Pharmaceutical Group Co., Ltd Fundamentals Summary

How do Yabao Pharmaceutical Group's earnings and revenue compare to its market cap?
600351 fundamental statistics
Market capCN¥4.38b
Earnings (TTM)CN¥220.70m
Revenue (TTM)CN¥2.83b

19.9x

P/E Ratio

1.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600351 income statement (TTM)
RevenueCN¥2.83b
Cost of RevenueCN¥1.32b
Gross ProfitCN¥1.51b
Other ExpensesCN¥1.29b
EarningsCN¥220.70m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.31
Gross Margin53.38%
Net Profit Margin7.79%
Debt/Equity Ratio3.1%

How did 600351 perform over the long term?

See historical performance and comparison

Dividends

2.5%

Current Dividend Yield

50%

Payout Ratio